These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1431420)
41. The Ba fragment of complement factor B inhibits human B lymphocyte proliferation. Ambrus JL; Peters MG; Fauci AS; Brown EJ J Immunol; 1990 Mar; 144(5):1549-53. PubMed ID: 2307833 [TBL] [Abstract][Full Text] [Related]
42. Adrenocorticotropin (ACTH) functions as a late-acting B cell growth factor and synergizes with interleukin 5. Brooks KH J Mol Cell Immunol; 1990; 4(6):327-35; discussion 335-7. PubMed ID: 1964384 [TBL] [Abstract][Full Text] [Related]
43. Tetracyclines inhibit activated B cell function. Kuzin II; Snyder JE; Ugine GD; Wu D; Lee S; Bushnell T; Insel RA; Young FM; Bottaro A Int Immunol; 2001 Jul; 13(7):921-31. PubMed ID: 11431422 [TBL] [Abstract][Full Text] [Related]
44. Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. Induction of human B cell responses by fixed activated T cells. Tohma S; Lipsky PE J Immunol; 1991 Apr; 146(8):2544-52. PubMed ID: 1707911 [TBL] [Abstract][Full Text] [Related]
45. Inhibitory influence of IL-4 on human B cell responsiveness. Jelinek DF; Lipsky PE J Immunol; 1988 Jul; 141(1):164-73. PubMed ID: 2837507 [TBL] [Abstract][Full Text] [Related]
46. Leukotriene B4 potentiates the expression and release of Fc epsilon RII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL-4. Dugas B; Paul-Eugene N; Cairns J; Gordon J; Calenda A; Mencia-Huerta JM; Braquet P J Immunol; 1990 Nov; 145(10):3406-11. PubMed ID: 2172383 [TBL] [Abstract][Full Text] [Related]
47. Regulatory effects of prostaglandin E2 on the growth and differentiation of human B lymphocytes activated through their CD40 antigen. Garrone P; Galibert L; Rousset F; Fu SM; Banchereau J J Immunol; 1994 May; 152(9):4282-90. PubMed ID: 7512590 [TBL] [Abstract][Full Text] [Related]
48. Species-nonspecific action of soluble immunosuppressive factor produced by murine immature erythroid cells. Mitasov AV; Tsyrlova IG; Kiselev SV; Kozlov VV Ann N Y Acad Sci; 1991; 628():399-409. PubMed ID: 2069316 [TBL] [Abstract][Full Text] [Related]
49. CD40 ligand triggers interleukin-6 mediated B cell differentiation. Urashima M; Chauhan D; Hatziyanni M; Ogata A; Hollenbaugh D; Aruffo A; Anderson KC Leuk Res; 1996 Jun; 20(6):507-15. PubMed ID: 8709623 [TBL] [Abstract][Full Text] [Related]
51. Ixodes ricinus tick salivary gland extract inhibits IL-10 secretion and CD69 expression by mitogen-stimulated murine splenocytes and induces hyporesponsiveness in B lymphocytes. Hannier S; Liversidge J; Sternberg JM; Bowman AS Parasite Immunol; 2003 Jan; 25(1):27-37. PubMed ID: 12753435 [TBL] [Abstract][Full Text] [Related]
52. Mechanisms of alcohol-induced suppression of B-cell response. Aldo-Benson M Alcohol Clin Exp Res; 1989 Aug; 13(4):469-75. PubMed ID: 2529792 [TBL] [Abstract][Full Text] [Related]
53. B cells as antigen-presenting cells: antigen-specific IL-2 production by cloned T cells without expression of IL-2 receptors. Kakiuchi T; Matsui M; Taira S; Nariuchi H; Osawa H; Diamantstein T Cell Immunol; 1987 Aug; 108(1):150-61. PubMed ID: 3111723 [TBL] [Abstract][Full Text] [Related]
54. Cholera toxin promotes B cell isotype switching by two different mechanisms. cAMP induction augments germ-line Ig H-chain RNA transcripts whereas membrane ganglioside GM1-receptor binding enhances later events in differentiation. Lycke NY J Immunol; 1993 Jun; 150(11):4810-21. PubMed ID: 8388421 [TBL] [Abstract][Full Text] [Related]
55. The effect of exogenous lymphokines on immunoglobulin production and lymphocyte proliferation in renal transplant patients. Cardella CJ; Weissgarten J; Ng CM; Friedman E Transplantation; 1989 Feb; 47(2):300-4. PubMed ID: 2645717 [TBL] [Abstract][Full Text] [Related]
56. Production of immunoglobulins by human sIgD+ and sIgD- human blood B lymphocytes in response to stimulation with activated T cells and agonistic antibodies; effect of IL-10, IL-2 and mode of activation of T cells. Ling NR; Brown B; Hardie D Clin Exp Immunol; 1995 Aug; 101(2):369-75. PubMed ID: 7544253 [TBL] [Abstract][Full Text] [Related]
57. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. Aversa G; Punnonen J; Cocks BG; de Waal Malefyt R; Vega F; Zurawski SM; Zurawski G; de Vries JE J Exp Med; 1993 Dec; 178(6):2213-8. PubMed ID: 7504061 [TBL] [Abstract][Full Text] [Related]
58. IL-4 promotes Stat6-dependent survival of autoreactive B cells in vivo without inducing autoantibody production. Morris SC; Dragula NL; Finkelman FD J Immunol; 2002 Aug; 169(4):1696-704. PubMed ID: 12165489 [TBL] [Abstract][Full Text] [Related]
59. Human interleukin 2 can promote the growth and differentiation of single hapten-specific B cells in the presence of specific antigen. Pike BL; Raubitschek A; Nossal GJ Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7917-21. PubMed ID: 6334854 [TBL] [Abstract][Full Text] [Related]
60. Augmentation by 2-mercaptoethanol of in vitro anti-TNP antibody production induced by butyrate plus IL-2 in murine splenic B cells. Gohda E; Okamura T; Aoyama E; Yamamoto I Immunopharmacol Immunotoxicol; 2003 Nov; 25(4):539-50. PubMed ID: 14686796 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]